Skip to main content
TrialFinder
TrialFinder is for informational purposes only and does not provide medical advice. Always talk to your doctor about whether a trial is right for you.
RECRUITINGOBSERVATIONAL

ATTR Cardiac Amyloidosis in a Selected Population

Prevalence and Long Tem Follow Up of ATTR Cardiac Amyloidosis in a Selected Population of Patients Operated on Carpal Tunnel Syndrome

Important: This information is not medical advice. Talk to your doctor about whether a clinical trial is right for you.

About This Trial

Patients operated for carpal tunnel syndrome (CTS) at Ålesund Hospital (200 patients) will have a biopsy to diagnose ATTR amyloidosis. Patients with positive biopsy will be examined to decide wether they have cardiac amyloidosis. All patients with positive biopsy will be followed closely for 10 years wit echocardiography an clinically.

Who May Be Eligible (Plain English)

Who May Qualify: - Male \> 50 years - Female \> 60 years - operated CTS at Ålesund Hospital Who Should NOT Join This Trial: - not consented - do not speak Norwegian - secondary cause of CTS as traumatic or rheumatic - cannot be followed \> 5 years due to other medical conditions - Cardiac disease at time of operation for CTS Always talk to your doctor about whether this trial is right for you.

Original Eligibility Criteria

View original clinical language
Inclusion Criteria: * Male \> 50 years * Female \> 60 years * operated CTS at Ålesund Hospital Exclusion Criteria: * not consented * do not speak Norwegian * secondary cause of CTS as traumatic or rheumatic * cannot be followed \> 5 years due to other medical conditions * Cardiac disease at time of operation for CTS

Locations (1)

Ålesund Hospital
Ålesund, Møre og Romsdal, Norway